Which of the following is the reason for including 1L-2 in the regimen? A 59-year-old woman with metastatic renal carcinoma is receiving cyclophosphamide, paclitaxel , and interleukin-2 (IL-2).
A. Decreasing bone marrow suppression B. Decreasing the likelihood of hemorrhagic cystitis C. Decreasing the likelihood of peripheral neuropathy D. Decreasing nausea and vomiting E. Stimulating T lymphocytes
The answer to this question is E. The main goal of the different medications and treatments that the patient is going through is to increase the T lymphocyte. This is a subtype of the white blood cell. The T-cell is in charge of hunting down the cells that should not be present in the system. There are different cells that may have an infection or they may be cancerous.
These cells will be eradicated by the T-cells effectively. This will make the immune system generally stronger against potential issues that people may encounter. The higher the immune system of individuals, the lesser the chances that they will suffer from different types of diseases.